These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 17162272

  • 21. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
    Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ.
    Circulation; 2009 Apr 07; 119(13):1703-10. PubMed ID: 19307481
    [Abstract] [Full Text] [Related]

  • 22. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C, Tome-Esteban M, Lambiase PD, Pantazis A, Dickie S, McKenna WJ, Elliott PM.
    Heart; 2013 Apr 07; 99(8):534-41. PubMed ID: 23339826
    [Abstract] [Full Text] [Related]

  • 23. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ.
    Eur Heart J; 2000 Dec 07; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract] [Full Text] [Related]

  • 24. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.
    Eur Heart J; 2007 Nov 07; 28(21):2583-8. PubMed ID: 17483110
    [Abstract] [Full Text] [Related]

  • 25. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 26. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep 01; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

  • 27. Hypertrophic cardiomyopathy--sports-related aspects of diagnosis, therapy, and sports eligibility.
    Hipp AA, Heitkamp HC, Röcker K, Dickhuth HH.
    Int J Sports Med; 2004 Jan 01; 25(1):20-6. PubMed ID: 14750008
    [Abstract] [Full Text] [Related]

  • 28. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M, Czarnecka D, Bacior B, Petkow-Dimitrow P, Wilczek R, Kawecka-Jaszcz K.
    Kardiol Pol; 2005 Aug 01; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [Abstract] [Full Text] [Related]

  • 29. [Risk stratification for sudden death in hypertrophic cardiomyopathy].
    Spirito P, Maron BJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr 01; 37(4):294-7. PubMed ID: 19791461
    [Abstract] [Full Text] [Related]

  • 30. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R, Minami Y, Haruki S, Kanbayashi K, Itani R, Suzuki A, Ejima K, Shiga T, Shoda M, Hagiwara N.
    Int J Cardiol; 2016 Jul 01; 214():419-22. PubMed ID: 27088403
    [Abstract] [Full Text] [Related]

  • 31. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M.
    J Card Fail; 2008 Jun 01; 14(5):414-9. PubMed ID: 18514934
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A, García-Pinilla JM, Cabrera-Bueno F, Fernández-Pastor J, Peña-Hernández J, Medina-Palomo C, Barrera-Cordero A, De Teresa E, Alzueta J.
    Europace; 2016 May 01; 18(5):773-7. PubMed ID: 25855675
    [Abstract] [Full Text] [Related]

  • 33. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.
    Heart; 2009 May 01; 95(9):709-14. PubMed ID: 19282314
    [Abstract] [Full Text] [Related]

  • 34. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
    Olivotto I, Montereggi A, Mazzuoli F, Cecchi F.
    G Ital Cardiol; 1999 Jan 01; 29(1):11-9. PubMed ID: 9987042
    [Abstract] [Full Text] [Related]

  • 35. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 36. Can sudden cardiac death be prevented?
    Maron BJ.
    Cardiovasc Pathol; 2010 Mar 01; 19(6):329-35. PubMed ID: 20378375
    [Abstract] [Full Text] [Related]

  • 37. [Implantable cardioverter defibrillators in pediatric patients: results in a series of 33 cases].
    Tisserant A, Sadoul N, Kouakam C, Kacet S, Rey C, Chauvin M, Lévy J, Mabo P, Marçon F.
    Arch Mal Coeur Vaiss; 2006 May 01; 99(5):433-8. PubMed ID: 16802731
    [Abstract] [Full Text] [Related]

  • 38. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?
    Östman-Smith I, Rossano JW, Shaddy RE.
    Curr Opin Cardiol; 2013 Mar 01; 28(2):130-8. PubMed ID: 23348710
    [Abstract] [Full Text] [Related]

  • 39. Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ.
    Card Electrophysiol Clin; 2015 Jun 01; 7(2):165-71. PubMed ID: 26002383
    [Abstract] [Full Text] [Related]

  • 40. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ, Fananapazir L.
    Circulation; 1992 Jan 01; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.